VivoSeq
Psychiatry

Cannabis

0

Pipeline Programs↗

17

Active Trials↗

4

Companies Involved↗

Cannabis is an early-stage landscape with 0 programs across 4 companies. The most active players are Jazz Pharmaceuticals, Breath of Life International Pharma Ltd, GreenCare Pharma.

Intelligence

Pipeline Metrics

Competitive Density

34/100

Pipeline Velocity

22/100

Mech. Concentration

N/A

Completion Rate

93/100

Attrition Rate

2/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Jazz Pharmaceuticals logo

Jazz Pharmaceuticals

0 programs

PreclinicalB

Breath of Life International Pharma Ltd

0 programs

PreclinicalG

GreenCare Pharma

0 programs

PreclinicalT

Tetra Bio-Pharma

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

48

clinical trials

Completed25 · 52%
Recruiting11 · 23%
Unknown status4 · 8%
Not yet recruiting4 · 8%
Active, not recruiting2 · 4%
Suspended1 · 2%
Other1 · 2%

Clinical Trials

Trial Activity

48 trials

Combined and Separate Effects of Cannabis and Tobacco: Psychomotor, Subjective and Physiological Outcomes
Recruiting·CCentre for Addiction and Mental Health·N/A·NCT05526196·60 enrolled
Age Differences in the Effects of Cannabis on Simulated Driving
Recruiting·CCentre for Addiction and Mental Health·N/A·NCT04325958·128 enrolled
Cannabidiol and Cannabis Concentrate Users
Recruiting·UUniversity of Colorado, Denver·Phase 2·NCT06575751·120 enrolled
The Impact of Product Formulation on the Pharmacokinetics and Pharmacodynamics of Cannabis Edibles
Recruiting·JJohns Hopkins University·Phase 1·NCT05602649·80 enrolled
High Potency Cannabis: Acute and Protracted Effects
Recruiting·UUniversity of California, Los Angeles·Phase 1·NCT06859723·30 enrolled
Impact of Daily Oral Cannabis Doses in Patients With Cancer
Recruiting·—·Phase 1·NCT06601218·80 enrolled
Safety and Pharmacokinetics of Extrato de Cannabis Sativa GreenCare
Recruiting·GGreenCare Pharma·Phase 1·NCT06807762·72 enrolled
Sex Hormones Impact on Cannabis Response
Recruiting·MMaastricht University·N/A·NCT07417059·21 enrolled
Brain Mechanisms Supporting Cannabis-induced Pain Relief
Recruiting·UUniversity of California, San Diego·Phase 1·NCT04982965·100 enrolled
E-cigarette Cessation in Adults Who Co-use Cannabis
Recruiting·MMedical University of South Carolina·Phase 4·NCT06688539·105 enrolled
In-Vehicle Real-Time Cannabis Influenced Driving Detection
Recruiting·UUniversity of Bern·N/A·NCT07401628·45 enrolled
Study on Regulated Cannabis Sales in Pharmacies
Active, not recruiting·UUniversity of Bern·N/A·NCT06120855·1,091 enrolled
Investigating The Effects Of Full-Spectrum Medicinal Cannabis Plant Extract 0.08% THC (NTI164) On Paediatric Acute-onset Neuropsychiatric Syndrome (PANS)
Active, not recruiting·FFenix Innovation Group·Phase 1/2·NCT06621888·18 enrolled
THC Titration of High-Potency Cannabis Concentrates
Not yet recruiting·CCentre for Addiction and Mental Health·N/A·NCT07105449·48 enrolled
Effects of Various Cannabis Strains on Perceptual, Subjective and Objective Use Outcomes
Not yet recruiting·JJohns Hopkins University·Phase 1·NCT07214155·70 enrolled
Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)